LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 65.70 | 84.90 | 7034 | 8484 | 0.8291 | 0.9444 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 65.70 | 84.90 | 7060 | 8484 | 0.8321 | 0.9454 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 67.41 | 84.90 | 572 | 8766 | 0.0652 | 0.3300 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 67.41 | 84.90 | 7672 | 8766 | 0.8752 | 0.9605 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 67.41 | 84.90 | 7342 | 8766 | 0.8375 | 0.9477 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 67.41 | 84.90 | 7379 | 8766 | 0.8417 | 0.9492 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 69.11 | 84.90 | 646 | 8988 | 0.0719 | 0.3522 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 69.11 | 84.90 | 7980 | 8988 | 0.8879 | 0.9649 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 69.11 | 84.90 | 7646 | 8988 | 0.8507 | 0.9525 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 69.11 | 84.90 | 7685 | 8988 | 0.8550 | 0.9540 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 70.81 | 84.90 | 703 | 9132 | 0.0770 | 0.3678 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 70.81 | 84.90 | 8126 | 9132 | 0.8898 | 0.9657 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 70.81 | 84.90 | 7835 | 9132 | 0.8580 | 0.9551 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 70.81 | 84.90 | 7872 | 9132 | 0.8620 | 0.9565 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 72.52 | 84.90 | 682 | 9214 | 0.0740 | 0.3609 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 72.52 | 84.90 | 8344 | 9214 | 0.9055 | 0.9709 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 72.52 | 84.90 | 8046 | 9214 | 0.8732 | 0.9603 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 72.52 | 84.90 | 8088 | 9214 | 0.8778 | 0.9618 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 74.22 | 84.90 | 696 | 9343 | 0.0745 | 0.3637 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 74.22 | 84.90 | 8568 | 9343 | 0.9170 | 0.9746 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 74.22 | 84.90 | 8206 | 9343 | 0.8783 | 0.9621 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 74.22 | 84.90 | 8242 | 9343 | 0.8821 | 0.9634 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 75.93 | 84.90 | 673 | 8970 | 0.0750 | 0.3606 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 75.93 | 84.90 | 8781 | 8970 | 0.9789 | 0.9937 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 75.93 | 84.90 | 8370 | 8970 | 0.9330 | 0.9795 | MN20160318_Q02 | G06 |